Skip Navigation

TAG ARCHIVES: Sézary syndrome

1 result


  • Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link

    October 8, 2025
    Russell Maas

    Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.